Healthcare >> CEO Interviews >> August 14, 2000
DR. GEORGE RATHMANN is currently Chairman, President and CEO of Hyseq,
Inc. and Chairman Emeritus of Amgen, Inc. and ICOS Corporation. He
served as Chairman, President and Chief Executive Officer at Amgen from
its inception in 1980 to October 1988, and Chairman from October 1988 to
July 1990. He served as Chairman of ICOS Corporation from 1990 until
January 2000. Before joining Amgen, Dr. Rathmann was Vice President of
Research and Development, Diagnostics Division, of Abbott Laboratories,
which he had joined in 1975. Previous experience included Litton
Industries, as President of Litton Medical Systems, Inc., and the 3M
Company. He is a member of the National Academy of Engineering, the
American Association for the Advancement of Science, and the American
Chemical Society. Since 1982, Dr. Rathmann has served as an Officer and
Board member of the Biotechnology Industry Organization and was Chairman
from 1986 to 1988. He is an Officer and Board member of the National
Science and Technology Medals Foundation. Dr. Rathmann is on the Board
of Trustees of the Fred Hutchinson Cancer Research Center, the Keystone
Center, and is a member of the Board of Directors of Somatogen, Inc. Dr.
Rathmann received his BS in Physical Chemistry from Northwestern
University, and his PhD in Physical Chemistry from Princeton University. Profile
to set the stage for our readers?
Dr. Rathmann: The company was started based on some discoveries, about
13 years ago,
